Using sampling “windows” for PK blood samples [Design Issues]

posted by jag009  – NJ, 2013-10-25 07:12 (4631 d 15:53 ago) – Posting: # 11763
Views: 8,534

Hi Mittyri,

❝ Nathan Teuscher does not explain a type of trial. So I'm interested in opinion of the colleagues who are working with BEQ protocols.


His conclusion was based on AUC being similar between the two sampling time schemes which I agree. For BE studies we need to determine both AUC and Cmax equivalence between test and reference. Therefore the PK time point selection is important (if not critical).

John

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
348 visitors (0 registered, 348 guests [including 17 identified bots]).
Forum time: 23:05 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5